Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Current Leases (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Current Leases for 3 consecutive years, with $286000.0 as the latest value for Q4 2025.

  • Quarterly Current Leases fell 90.45% to $286000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $286000.0 through Dec 2025, down 90.45% year-over-year, with the annual reading at $286000.0 for FY2025, 90.45% down from the prior year.
  • Current Leases hit $286000.0 in Q4 2025 for Camp4 Therapeutics, up from $27000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $3.1 million in Q2 2025 to a low of $27000.0 in Q3 2025.
  • Historically, Current Leases has averaged $1.0 million across 3 years, with a median of $286000.0 in 2025.
  • Biggest five-year swings in Current Leases: skyrocketed 745.76% in 2024 and later crashed 90.45% in 2025.
  • Year by year, Current Leases stood at $354000.0 in 2023, then surged by 745.76% to $3.0 million in 2024, then crashed by 90.45% to $286000.0 in 2025.
  • Business Quant data shows Current Leases for CAMP at $286000.0 in Q4 2025, $27000.0 in Q3 2025, and $3.1 million in Q2 2025.